News

NRT Smoking Cessation Aids in China Report Offers a Comprehensive Guide to the Size and Shape of the Market at a National Level

DUBLIN, Ireland-(Business Wire)-December 7, 2007 - Research and Markets (http://www.researchandmarkets.com/reports/c76578) has announced the addition of "NRT Smoking Cessation Aids in China" to their offering.

Our "NRT Smoking Cessation Aids in China" report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

— Get a detailed picture of the smoking cessation aids industry

— Pinpoint growth sectors and trends and identify factors driving change

— Understand the competitive environment, the market's major players and leading brands

— Use five-year forecasts to assess how the market is predicted to develop

Executive Summary:

Strong Growth Due To Rising Incomes and Awareness

There was strong growth across OTC healthcare in 2006. Growth was supported by continued expansion in the Chinese economy, with rising income levels enabling consumers to buy more OTC healthcare. This drove growth in basic products such as analgesics and cough, cold and allergy (hay fever) remedies. Rising incomes also resulted in richer and less healthy diets, boosting digestive remedies, while increased pollution supported growth in allergy remedies and medicated skin care. In addition, consumers became more aware of OTC healthcare and more confident in self-medication, while health and wellness trends boosted vitamins and dietary supplements. Consumers also became more confident in discussing once-taboo ailments, with this boosting products such as vaginal antifungals and haemorrhoid treatments.

Amway Leads Despite Difficulties

Amway remained the leading player in 2006, with a share considerably higher than any of its competitors. This was despite seeing a sharp drop in share over 2005, as it attempted to reconcile its sales representatives to a new business structure in line with new direct sales legislation. Amway is only present in vitamins and dietary supplements, which dominates overall OTC healthcare. Direct sales is particularly strong in vitamins and dietary supplements, due to its representatives being able to offer individual guidance to often-confused customers and with distribution expanding rapidly across the country.

Specialist Channels Continue To Dominate

Chemists/pharmacies and drugstores/parapharmacies jointly dominated value sales of OTC healthcare in 2006. Many OTC healthcare products are indeed only permitted for sale via these channels. However, these channels both lost share during the review period as distribution widened for many products. Discounters notably gained share across OTC healthcare in the latter half of the review period, as this channel's low prices appealed to price-sensitive consumers. Direct sales also gained share rapidly, due to its growing presence in dominant vitamins and dietary supplements.

Good Growth To Continue As Distribution and Self-medication Widens

OTC healthcare is expected to see slower but still strong growth during the forecast period. Many products are seeing increasing maturity in larger cities, notably analgesics and vitamins and dietary supplements, with this expected to dampen growth. Growth will continue to be supported by distribution widening to include smaller cities and rural areas, however. In addition, growth will be boosted by consumers' growing confidence in selfmedication, with most happy to choose basic OTC healthcare themselves.

OTC HEALTHCARE IN CHINA : MARKET INSIGHT

EXECUTIVE SUMMARY

Strong growth due to rising incomes and awareness

Emergency contraception benefits from government campaigns

Amway leads despite difficulties

Specialist channels continue to dominate

Good growth to continue as distribution and self-medication widens

KEY TRENDS AND DEVELOPMENTS

Rising income levels boost sales

Traditional Chinese medicine continues to grow in popularity

Growing interest in self-medication and health and wellness

Grooming and appearance become increasingly important

Specialist channels see dominance eroded

TERRITORY KEY TRENDS AND DEVELOPMENTS

East China

Mid China

North and Northeast China

Northwest China

South China

Southwest China

MARKET INDICATORS

Table 1 Life Expectancy at Birth 2001-2006

MARKET DATA

Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006

Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006

Table 4 Sales of OTC Healthcare by Region: Value 2001-2006

Table 5 Sales of OTC Healthcare by Region: % Value Growth 2001-2006

Table 6 OTC Healthcare Company Shares by Retail Value 2002-2006

Table 7 OTC Healthcare Brand Shares by Retail Value 2003-2006

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011

Table 12 Forecast Sales of OTC Healthcare by Region: Value 2006-2011

Table 13 Forecast Sales of OTC Healthcare by Region: % Value Growth 2006-2011

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Generics

Consumer expenditure on health goods and medical services

Consumer Expenditure on Health Goods and Medical Services

Table 14 Consumer Expenditure on Health Goods and Medical Services 2001-2006

DEFINITIONS

Sources

Summary 1 Research Sources

LOCAL COMPANY PROFILES - CHINA

AMWAY (CHINA) CO LTD - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 2 Amway (China) Co Ltd: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 3 Amway (China) Co Ltd: Competitive Position 2006

BRISTOL-MYERS SQUIBB CO - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 4 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts

Summary 5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 6 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2006

GUANGZHOU PAN GAO SHOU PHARM CO LTD - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 7 Guangzhou Pan Gao Shou Pharm Co Ltd: Key Facts

Summary 8 Guangzhou Pan Gao Shou Pharm Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 9 Guangzhou Pan Gao Shou Pharm Co Ltd: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 10 Guangzhou Pan Gao Shou Pharm Co Ltd: Competitive Position 2006

HARBIN PHARMACEUTICAL GROUP SANJING PHARM CO LTD - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 11 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Key Facts

Summary 12 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 13 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Competitive Position 2006

KUNMING DIANHONG PHARM CO LTD - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 14 Kunming Dianhong Pharm Co Ltd: Key Facts

Summary 15 Kunming Dianhong Pharm Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 16 Kunming Dianhong Pharm Co Ltd: Competitive Position 2006

SHANGHAI JIAO DA ONLLY CO LTD - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 17 Shanghai Jiao Da Onlly Co Ltd: Key Facts

Summary 18 Shanghai Jiao Da Onlly Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 19 Shanghai Jiao Da Onlly Co Ltd: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 20 Shanghai Jiao Da Onlly Co Ltd: Competitive Position 2006

TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT CO LTD - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 21 Tianjin Tianshi Biological Development Co Ltd: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 22 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2006

TIBET LINZHI QIZHENG TIBETAN MEDICINE FTY - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 23 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts

Summary 24 Tibet Linzhi Qizheng Tibetan Medicine Fty: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 25 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2006

WYETH PHARMACEUTICAL CO LTD - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 26 Wyeth Pharmaceutical Co Ltd: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 27 Summary Wyeth Pharmaceutical Co Ltd: Competitive Position 2006

XIAN JANSSEN PHARMACEUTICAL LTD - OTC HEALTHCARE - CHINA

STRATEGIC DIRECTION

KEY FACTS

Summary 28 Xian Janssen Pharmaceutical Ltd: Key Facts

Summary 29 Xian Janssen Pharmaceutical Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 30 Xian Janssen Pharmaceutical Ltd: Competitive Position 2006

NRT SMOKING CESSATION AIDS IN CHINA

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR INDICATORS

Table 15 Number of Smokers by Gender 2001-2006

SECTOR DATA

Table 16 Sales of Smoking Cessation Aids by Subsector 2001-2006

Companies mentioned:

— Xian Janssen Pharmaceutical Ltd

— Tibet Linzhi Qizheng Tibetan Medicine Fty

— Tianjin Tianshi Biological Development Co Ltd

— Bristol-Myers Squibb (Shanghai) Trading Co Ltd

— Guangzhou Pan Gao Shou Pharm Co Ltd

— Wyeth Pharmaceutical Co Ltd

— Bristol-Myers Squibb (Shanghai) Trading Co Ltd

— Harbin Pharmaceutical Group Sanjing Pharm Co Ltd

— Amway (China) Co Ltd

— Kunming Dianhong Pharm Co Ltd

— Shanghai Jiao Da Onlly Co Ltd

For more information visit http://www.researchandmarkets.com/reports/c76578

Press Release Network Ads

Google

Submit Your Press Release

Have a press release? Submit it to our press release networks.